# CureLauncher

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/curelauncher

- Industry: Healthcare
- Headquarters: Bloomfield Hills, US
- Website: curelauncher.com
- Total disclosed funding: $0.5M
- Latest round: Series B (Sep 12, 2014)
- Investors on record: 1

## About

CureLauncher is a company focused on improving healthcare delivery through innovative solutions that streamline patient access to clinical trials and therapies, enhancing efficiency and effectiveness in medical research.CureLauncher specializes in connecting patients to clinical trials and therapies. Founded by Steve Goldner, the company is headquartered in Bloomfield Hills, US. In September 2014, it completed a Series B funding round, raising USD 0.5 mn from IncWell, marking a significant milestone in its funding journey.CureLauncher offers a suite of products aimed at enhancing patient engagement and access to clinical trials, thereby addressing specific challenges within the healthcare sector. Their flagship products have gained traction in North America, Europe, and parts of Asia, catering to both businesses and individual users, including healthcare providers and patients seeking therapeutic options.The company generates revenue through direct sales and subscription-based services, providing a straightforward purchasing process for clients. Pricing plans are tiered to accommodate different customer segments, allowing access to high-quality solutions that are designed to enhance operational efficiency in healthcare settings.CureLauncher plans to leverage its recent Series B funding of USD 0.5 mn to develop new products tailored for improving access to clinical trials by 2015. The company aims to expand its geographic footprint into additional European and Asian markets by 2016 while enhancing its existing offerings to better serve both healthcare providers and patients.

## Funding rounds

- Series B, Sep 12, 2014, $0.5M — IncWell

## Investors

- IncWell (https://capitalatlas.ai/funds/incwell) — Series B